27783097|t|Breast cancer cells and bone marrow mesenchymal stromal cells: a regulated modulation of the breast tumor in the context of immune response
27783097|a|The role of direct cell-cell interactions mediating selective bone metastasis by breast cancer cells (BCCs) niche is still mostly unknown. Conditioned medium and direct cell-cell contacts experiments were used to investigate the effect of bone marrow -derived mesenchymal stromal cells (MSCs), osteoprogenitor-like cells (MG-63) and osteosarcoma cells (SaOS-2) on luminal-like (MCF-7) and basal-like (MDA-MB-231) BCCs flow cytometry was used to assess the purity of isolated BCCs and osteoblasts. Expression of osteoblastic markers was investigated by semi-quantitative RT-PCR. RANKL and OPG levels were measured by ELISA. Conditioned medium from MSCs and osteoblasts induced the expression of osteoblastic markers in BCCs. While co-culture assays with SaOS-2 increased the expression of osteoblastic markers in MCF-7 cells, SaOS-2 cell conditioned medium increased the expression of RANKL, PTHrP, VEGF and NOGGIN in MCF-7 cells. Co-cultures with either MG-63 cells or MSCs induced OPG and MMP-2 in both tumor cell lines. Interestingly, conditioned medium from co-cultures of MSCs and MDA-MB-231 cells significantly decreased the proliferation of activated T lymphocytes which was reversed by addition of anti-OPG antibodies to the co-cultures. Our data suggest that MSCs strongly contribute to the adaptation and invasiveness of breast cancer cells in skeletal tissues.
27783097	0	19	Breast cancer cells	T025	C1512505
27783097	24	35	bone marrow	T024	C0005953
27783097	36	61	mesenchymal stromal cells	T025	C3178844
27783097	93	105	breast tumor	T191	C1458155
27783097	113	120	context	T078	C0449255
27783097	124	139	immune response	T042	C0301872
27783097	159	181	cell-cell interactions	T043	C0007582
27783097	202	206	bone	T024	C0391978
27783097	207	217	metastasis	T191	C0027627
27783097	221	240	breast cancer cells	T025	C1512505
27783097	242	246	BCCs	T025	C1512505
27783097	279	297	Conditioned medium	T130	C0162518
27783097	309	327	cell-cell contacts	T043	C0007582
27783097	353	364	investigate	T169	C1292732
27783097	369	375	effect	T080	C1280500
27783097	379	390	bone marrow	T024	C0005953
27783097	400	425	mesenchymal stromal cells	T025	C3178844
27783097	427	431	MSCs	T025	C3178844
27783097	434	460	osteoprogenitor-like cells	T025	C0007634
27783097	462	467	MG-63	T025	C0007634
27783097	473	491	osteosarcoma cells	T025	C0007634
27783097	493	499	SaOS-2	T025	C0007634
27783097	504	516	luminal-like	T025	C0007634
27783097	518	523	MCF-7	T025	C0007634
27783097	529	539	basal-like	T025	C0596155
27783097	541	551	MDA-MB-231	T025	C0596155
27783097	553	557	BCCs	T025	C1512505
27783097	558	572	flow cytometry	T059	C0016263
27783097	585	591	assess	T058	C0184514
27783097	596	602	purity	T081	C1882508
27783097	606	614	isolated	T169	C0205409
27783097	615	619	BCCs	T025	C1512505
27783097	624	635	osteoblasts	T025	C0029418
27783097	637	647	Expression	T045	C1171362
27783097	651	663	osteoblastic	T025	C0029418
27783097	664	671	markers	T201	C0005516
27783097	676	688	investigated	T169	C1292732
27783097	692	709	semi-quantitative	T081	C0522525
27783097	710	716	RT-PCR	T063	C0599161
27783097	718	723	RANKL	T116,T123	C0666364
27783097	728	731	OPG	T116,T192	C0538161
27783097	732	738	levels	T080	C0441889
27783097	744	752	measured	T080	C0444706
27783097	756	761	ELISA	T059	C0014441
27783097	763	781	Conditioned medium	T130	C0162518
27783097	787	791	MSCs	T025	C3178844
27783097	796	807	osteoblasts	T025	C0029418
27783097	820	830	expression	T045	C1171362
27783097	834	846	osteoblastic	T025	C0029418
27783097	847	854	markers	T201	C0005516
27783097	858	862	BCCs	T025	C1512505
27783097	870	880	co-culture	T059	C0282547
27783097	881	887	assays	T059	C1510438
27783097	893	899	SaOS-2	T025	C0007634
27783097	900	909	increased	T081	C0205217
27783097	914	924	expression	T045	C1171362
27783097	928	940	osteoblastic	T025	C0029418
27783097	941	948	markers	T201	C0005516
27783097	952	963	MCF-7 cells	T025	C0007634
27783097	965	976	SaOS-2 cell	T025	C0007634
27783097	977	995	conditioned medium	T130	C0162518
27783097	996	1005	increased	T081	C0205217
27783097	1010	1020	expression	T045	C1171362
27783097	1024	1029	RANKL	T116,T123	C0666364
27783097	1031	1036	PTHrP	T116,T125	C0070099
27783097	1038	1042	VEGF	T116,T123	C0078058
27783097	1047	1053	NOGGIN	T116,T123	C4084599
27783097	1057	1068	MCF-7 cells	T025	C0007634
27783097	1070	1081	Co-cultures	T059	C0282547
27783097	1094	1105	MG-63 cells	T025	C0007634
27783097	1109	1113	MSCs	T025	C3178844
27783097	1114	1121	induced	T169	C0205263
27783097	1122	1125	OPG	T116,T192	C0538161
27783097	1130	1135	MMP-2	T116,T126	C0623362
27783097	1144	1160	tumor cell lines	T025	C0085983
27783097	1177	1195	conditioned medium	T130	C0162518
27783097	1201	1212	co-cultures	T059	C0282547
27783097	1216	1220	MSCs	T025	C3178844
27783097	1225	1241	MDA-MB-231 cells	T025	C0596155
27783097	1242	1265	significantly decreased	T081	C4055638
27783097	1270	1283	proliferation	T043	C0596290
27783097	1287	1310	activated T lymphocytes	T025	C2737322
27783097	1345	1364	anti-OPG antibodies	T116,T129	C0003241
27783097	1372	1383	co-cultures	T059	C0282547
27783097	1389	1393	data	T078	C1511726
27783097	1394	1401	suggest	T078	C1705535
27783097	1407	1411	MSCs	T025	C3178844
27783097	1421	1431	contribute	T052	C1880177
27783097	1439	1449	adaptation	T038	C0392673
27783097	1454	1466	invasiveness	T080	C1301757
27783097	1470	1489	breast cancer cells	T025	C1512505
27783097	1493	1509	skeletal tissues	T024	C0586827